Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

COVID-19 to impact general surgery procedures in U.S. in 2020, says GlobalData

Most of the hernia procedures to be performed in the U.S. will be delayed due to the COVID-19 crisis, with the exception of a minority of symptomatic cases, but will start to resume towards the end of the second quarter (Q2) of 2020, according to data and analytics company GlobalData.

GlobalData estimates that 41.1% of general surgery procedures performed in the U.S. are essential procedures while 58.9% are elective. Of the 58.9% of procedures that are elective, the top 10 procedures accounted for 42.0% of the total volume and included endoscopies, laparoscopies, biopsies, sterilization procedures and reconstructive surgeries. The top essential procedures include removal of cancerous tumors, hernia repairs, colectomies and deliveries.

Eric Chapman, medical devices analyst at GlobalData, says, “GlobalData expects that procedure rates will return to pre-COVID-19 levels by the fourth quarter (Q4) of 2020, and that the backlog of surgeries will not be cleared until Q4 2022.”

Since general surgery is grouped into essential and elective procedures, the impact of COVID-19 will depend on the urgency of the specific procedure. Furthermore, while 58.9% of procedures are considered to be elective, some cannot be delayed for long periods of time.

However, the ability to perform these surgeries will be affected by the number of available hospital beds, ventilators and PPE, since this type of medical equipment is being used for COVID-19 patients in critical condition. Operations should only be performed if they will not result in long hospital stays, if delaying the procedure is likely to prolong future hospital stays, or if delays would cause harm to the patient.

Chapman concludes, “GlobalData predicts that procedures such as removal of a vascular access devices, reconstruction of the chest wall, cholecystectomy and enterostomy closure will be canceled or delayed. However, these procedures are likely to resume by June, as further delays may cause risks to patients.”



Submit a Comment

Your email address will not be published. Required fields are marked *